All relevant data are within the paper and its Supporting Information files.

Introduction {#sec001}
============

Synapses are dynamic neural structures that can exhibit a turnover of hours \[[@pone.0184238.ref001]--[@pone.0184238.ref003]\] and are influenced by day/light cycle, age, and learning \[[@pone.0184238.ref004]--[@pone.0184238.ref008]\] among other physiological processes. Molecular mechanisms that could account for building/removal of synapses within these short times are largely unknown. Changes in synapse number, even if relatively small, can elicit notable changes in behavior \[[@pone.0184238.ref009], [@pone.0184238.ref010]\], or result in neural disorders \[[@pone.0184238.ref011]\]. For example, a mild 16% loss of inhibitory synapses has been reported in the cortex of schizophrenia patients \[[@pone.0184238.ref012]\]. Also, subtle perceptual and cognitive impairments manifest as a consequence of changes in the number of synapses well before cells are definitively lost by irreversible neurodegeneration \[[@pone.0184238.ref013], [@pone.0184238.ref014]\].

Extensive previous studies have identified proteins and processes that mediate synapse development and turnover. These include neurotrophins and neuropeptides \[[@pone.0184238.ref015]--[@pone.0184238.ref017]\], trafficking of receptors to and from the synapse \[[@pone.0184238.ref018]\], components such as N-cadherin \[[@pone.0184238.ref019]\], CaMKII \[[@pone.0184238.ref020], [@pone.0184238.ref021]\] or PSD-95 \[[@pone.0184238.ref022]\]. Also, synapse activity contributes to refine the number of synapses in a relatively long term basis \[[@pone.0184238.ref023], [@pone.0184238.ref024]\]. However, prior to these mechanisms of synapse maintenance, a different set of signals are required to initiate synaptogenesis and to cancel it when the appropriate number of them is reached. Different neuron types have characteristic numbers of synapses. In general, neuron size and synapse number correlate positively \[[@pone.0184238.ref025], [@pone.0184238.ref026]\]. Nonetheless, the neuron-type specific number of synapses, "the correct number", can fluctuate according to normal physiology, and these fluctuations can occur in the range of hours \[[@pone.0184238.ref027], [@pone.0184238.ref028]\]. Several proteins have been reported to signal for synaptogenesis in *Drosophila* \[[@pone.0184238.ref002], [@pone.0184238.ref029], [@pone.0184238.ref030]\] and vertebrates \[[@pone.0184238.ref031]--[@pone.0184238.ref033]\]. However, their hierarchy has not been established yet, nor a regulatory mechanism that could account for a rapid change in the number of synapses has been proposed.

As it is well known, different signaling pathways may share components depending on the cell type, physiological process or developmental context \[[@pone.0184238.ref034], [@pone.0184238.ref035]\]. For example, PI3K has been identified in multiple pathways downstream of various receptor types including tyrosine-kinase, G-protein-coupled and integrins \[[@pone.0184238.ref036], [@pone.0184238.ref037]\]. This scenario justifies the need to study a signaling pathway in a defined cell type rather than assuming that interactions described in a given context will apply to all cell types. Also, the biological relevance of molecular interactions requires to be validated under *in vivo* conditions. Here, we set out to identify the up- and down-stream components from PI3K, a key factor that we previously identified as a modulator of synaptogenesis in identified *Drosophila* neurons \[[@pone.0184238.ref002]\] and which is conserved in mammalian hippocampal cells \[[@pone.0184238.ref032]\]. We revisited other elements known to be involved in synaptogenesis, and analyzed their functional hierarchy by epistasis assays. In the course of our study, however, we identified and characterized an antagonistic signaling that counterbalances the pro-synaptogenesis pathway. Both pathways cross-regulate each other suggesting that the final number of synapses result from the equilibrium between their respective signaling activities.

Neurites, varicosities (a.k.a. boutons) and synapses are morphologically different features in a neuron and, consequently, the signaling for their genesis is also different. For example, while AKT promotes collateral branching and synapse formation \[[@pone.0184238.ref002], [@pone.0184238.ref038]\], FAK reduces branching but promotes synapses \[[@pone.0184238.ref039]\]. Also, small GTPases show differential localization in postsynaptic spines *vs* axon collateral branches \[[@pone.0184238.ref040]\]. Even collaterals from the same axon exhibit different ways of branching (reviewed in \[[@pone.0184238.ref041], [@pone.0184238.ref042]\]). These facts, justify to count synapses directly in this study, rather than using bouton number as a proxy.

Material and methods {#sec002}
====================

Fly stocks {#sec003}
----------

The class I phosphoinositide kinase PI3K is represented in *Drosophila* by Dp110. All fly constructs used here correspond to Dp110 but, for simplicity, we refer to them as PI3K. The pan-neural driver *elav-Gal4* (*w\*; P{w\[+mC\] = GAL4-elav*.*L}3*) \[[@pone.0184238.ref043]\] and those affecting motor neurons, *D42-Gal4 (w\*; P{w\[+mW*.*hs\] = GawB}D42)* \[[@pone.0184238.ref044]\], as well as lines *myc-PI3K (w*^*1118*^*;P{w\[+mC\] = Myc-Dp110}1)*, *myc-PI3K*^*ΔRBD*^ (*w*^*1118*^*;P{w\[+mC\] = Myc-Dp110\[RBD\]}1*), *UAS-PI3K*^*92E*.*CAAX*^ *(P{w\[+mC\] = Dp110-CAAX}1*, *y*^*1*^ *w\**) \[[@pone.0184238.ref045]\], *UAS-Bsk (w\*; P{w\[+mC\] = UAS-bsk*.*B}2)*, *UAS-Bsk*^*DN*.^ (*w*^*1118*^ *P{w\[+mC\] = UAS-bsk*.*DN}2*) \[[@pone.0184238.ref046]\], *UAS-hep* (*w*^*\[*^\*^*\]*^*; P{w\[+mC\] = UAS-hep*.*B}2*) \[[@pone.0184238.ref047]\], *UAS-htl* (*y*^*1*^ *w\*; P{w\[+mC\] = UAS-htl*.*M}YYDFR-F16*), *htl*^*AB42*^ (*w\*; htl*^*AB42*^*red e/TM3*, *P{ry\[+t7*.*2\] = ftz/LacZ}SC1*, *ry*^*RK*^ *Sb*^*1*^ *Ser*^*1*^), *btl*^*dev1*^ (*btl*^*dev1*^*/TM1*, *T(2;3)D*^*7*^, *red*^*1*^ *D*^*7*^) \[[@pone.0184238.ref048]\], *UAS-Fos* (*w*^*1118*^*; P{w\[+mC\] = UAS-Fra}2*), *UAS-Jun* (*y*^*1*^ *w*^*1118*^*; P{UAS-Jra}2*) \[[@pone.0184238.ref049]\], *UAS-Fos*^*DN*^ (*w*^*1118*^*; P{w\[+mC\] = UAS-Fra*.*Fbz}5*), *UAS-Jun*^*DN*^ (*w*^*1118*^*; P{w\[+mC\] = Jbz}1*) \[[@pone.0184238.ref050]\], *UAS-Ras85D* (*w\*; P{w\[+mC\] = UAS-Ras85D*.*K}5--1*), *UAS-Ras*^*DN*^ (*P{w\[+mC\] = UAS-ras*.*N17}TL1*, *w*^*1118*^) \[[@pone.0184238.ref051], [@pone.0184238.ref052]\], *UAS-Ras64B (w\[\*\]; P{w\[+mC\] = UAS-Ras64B*.*V14}1)*, *UAS-Ask1*^*RNAi*^ *(y*^*1*^ *sc\* v*^*1*^*; P{y\[+t7*.*7\] v\[+t1*.*8\] = TRiP*.*GL00238}attP2)*, *UAS-Mad*^*RNAi*^ (*y*^*1*^ *v*^*1*^*; P{y\[+t7*.*7\] v\[+t1*.*8\] = TRiP*.*JF01263}attP2*), *UAS-Licorne (y*^*1*^ *w*^*67c23*^ *P{y\[+t7*.*7\] = Mae-UAS*.*6*.*11}lic\[GG01785\])*, *UAS-Rala*^*DN*^ (*w\*; P{w\[+mC\] = UAS-Rala*.*S25N}2*), *UAS-Slpr*^*RNAi*^ ([*y*^*1*^](http://flybase.org/reports/FBal0018607.html) *sc\** [*v1*](http://flybase.org/reports/FBal0017656.html)*;* [*P{TRiP*.*HMS00742}attP2*](http://flybase.org/reports/FBti0140456.html)), *UAS-put*^*RNAi*^ *(*[*y*^*1*^](http://flybase.org/reports/FBal0018607.html) *sc\** [*v1*](http://flybase.org/reports/FBal0017656.html)*;* [*P{TRiP*.*HMS01944}attP40*](http://flybase.org/reports/FBti0149687.html)), *actin-Gal4* (*P{Act5C-GAL4}*) and *tub*^*LL7*^*-Gal4* (*P{tubP-GAL4}*) were from Bloomington Stock Center (NIH P40OD018537) (<http://flystocks.bio.indiana.edu/>). The other driver used in motor neurons, *OK6-Gal4*, was a gift from Cahir J. O'Kane (University of Cambridge, United Kingdom) \[[@pone.0184238.ref053]\]. Strains *UAS-PI3K (y*^*1*^ *w*^*1118*^*;P{w\[+mC\] = UAS-PI3K92E*.*Exel}2*) and *UAS-PI3K*^*DN*^ (*y*^*1*^ *w\*; P{w\[+mC\] = Dp110\[D954A\]}2*) \[[@pone.0184238.ref054]\] were provided by Dr. J. Botas (Baylor College of Medicine, Houston, TX). Strains *UAS-Hiw* (*P{UAS-hiw*.*W}*) \[[@pone.0184238.ref055]\], *UAS-wit* (*P{UAS-wit*.*M}*), *wit*^*B11*^ (*bw*^*1*^*; wit*^*B11*^ *st*^*1*^*/TM6B*, *Tb*^*1*^), *wit*^*A12*^ (*bw*^*1*^*; wit*^*A12*^ *st*^*1*^*/TM6B*, *Tb*^*1*^) \[[@pone.0184238.ref056]\], *UAS-gbb* (*P{UAS-gbb*.*K}*) \[[@pone.0184238.ref057]\], *gbb*^*1*^, *gbb*^*2*^ \[[@pone.0184238.ref058]\] *UAS-Mad*^*\#2A3*^ and *UAS-Medea*^*\#5*.*13A3*^ \[[@pone.0184238.ref059]\] were a gift from Dr. G. Marqués (University of Minnesota). Strains *UAS-Wnd* (*w\*; P{w\[+mC\] = UAS-wnd*.*C}2*) (50), H*iw*^*ND8*^ (*w\* hiw*^*ND8*^) \[[@pone.0184238.ref060]\] and H*iw*^*ΔE3*^ (55) were kindly provided by Dr. A. DiAntonio (University of Washington in St. Louis, USA). Driver *Mhc-Gal4* (*P{Mhc-GAL4*.*U}*) \[[@pone.0184238.ref061]\] was used to target the postsynaptic cell. The *puc*^*RNAi*^ (GD3018), *p38a*^*RNAi*^ (KK102484), *Medea*^*RNAi*^ (GD19689) and *Mad*^*RNAi*^ (KK110517) strains were from the Vienna Stock Center (<http://stockcenter.vdrc.at/control/main>). The microRNA *UAS-bantamA* strain (*M{UAS-ban*.*S}ZH-86Fb*) \[[@pone.0184238.ref062]\] was provided by Dr. M. Milán (IRB, Barcelona, Spain), and line *UAS-cic(3xHA) att86Fb* (F001848) was from Dr. G. Jiménez (IBMB, Barcelona).

Validation of genetic tools and procedures {#sec004}
------------------------------------------

For down-expression experiments, mutants or dominant negative forms were used when available. In a few cases, RNAi constructs were employed as an alternative. All RNAi lines used in this study do not have reported off-targets. In addition, their effectiveness was tested with general Gal4 drivers (*gmr-Gal4*, *tub*^*LL7*^*-Gal4* or *actin-Gal4*) under the criterion of morphological or adult viability phenotypes. Furthermore, some genetic combinations were also tested for protein effects in Western blots (see main Text). The RNAi that, having passed the previous criteria, failed to yield a synaptic phenotype constitute an innocuous RNAi control (see [S1 Table](#pone.0184238.s004){ref-type="supplementary-material"}). The synaptic value of reference corresponds to genotypes in which the Gal4 drives neutral *UAS-GFP* or *UAS-LacZ* constructs. To count synapses, the *D42-Gal4* driver was used throughout, while for qPCR assays, we used the *elav-Gal4*. All synapse counts correspond to the larval motor neuron 6/7 from abdominal segment A3. Only one neuromuscular junction per crawling LIII larvae was used in order to maximize the stochastic variability and, hence, to increase the biological relevance of the statistical differences. Cultures were kept at 25°C and reared under non-crowding conditions, 10--15 males and 20--30 females per vial changed every other day. All genotypes were obtained from crosses repeated over a two years period.

Experimental cell system {#sec005}
------------------------

The neuromuscular junction (NMJ) of third larval instar \[[@pone.0184238.ref063]\] was used as experimental system. Boutons are often used as a surrogate of synapses in quantitative studies of synaptogenesis. However, common experience shows that synapses are not confined to boutons, and boutons can be devoid of synapses. To avoid these caveats, we adopted the criterion of counting the total number of mature active zones per neuromuscular junction irrespective of their bouton allocation. Genetic manipulations were driven to selected motor neurons using the binary Gal4/UAS system \[[@pone.0184238.ref064]\]. Synapses were visualized under confocal microscopy by the monoclonal antibody nc82 (1:10, DSHB, IA) which identifies the Bruchpilot protein, homolog to the mammalian CAST \[[@pone.0184238.ref065]\], and serves as an active zone-specific marker \[[@pone.0184238.ref002], [@pone.0184238.ref066]--[@pone.0184238.ref068]\] located at the edge of the characteristic T bar specialization of fly synapses \[[@pone.0184238.ref069]\]. The neuronal membrane was labeled with rabbit anti-HRP (1:200, Jackson ImmunoResearch). The secondary antibodies used were Alexa 488 (goat anti-mouse, 1:500, Molecular Probes) and Alexa 568 (goat anti-rabbit, 1:500, Molecular Probes). Larvae were mounted in Vectashield (Vector Labs).

Image acquisition and synapse number quantification {#sec006}
---------------------------------------------------

Confocal Images were acquired with a Leica Confocal Microscope TCS SP5 II (Mannheim, Germany). Synapse number was determined in all genotypes using the IMARIS software (Bitplane). Since IMARIS performs 3D reconstructions of the neuromuscular junction, the identification of synapses can be considered as reliable. Finally, to avoid misidentification of synapses, a threshold was stablished and a quality filter of shape and size was applied in all cases to unambiguously count synapses independently of changes of branching, length or area in the selected motor neurons. To stablish the threshold, we choose a confocal plane to measure the size of the nc82-positive spots present in that plane irrespective of whether they are contained within a bouton or along the axon. These measurements provide an average value that, for the acquisition conditions at 63x magnification (1024x256 pixels), corresponds to 0.5μm. This value is consistent with the synapse size as determined by transmission electron microscopy, and was fed to the software to count rounded spots of that size. Parameters were kept constant throughout the study of all genotypes.

Quantitative PCR {#sec007}
----------------

mRNA extractions from third instar larvae were obtained through standard protocols using TRIZOL (Invitrogen) and kept frozen at -80°C. SuperSCript II Reverse Transcriptase (*Invitrogen*) was used with 5 μg of mRNA of each sample following the manufacturer instructions. Quantification of gene expression was determined using specific Taqman probes (*Applied Biosystems*). Each reaction was done in triplicate and with at least three different samples of each genotype.

Western blotting {#sec008}
----------------

For biochemical assays, 5--10 fly heads were homogenized in 20 μl of lysis buffer containing NaCl 150 mM, 0.05% Tween-20 and TBS pH 7.5. For detection of pAKT protein, approximately 5--10 head equivalents of protein extract were analyzed on a 4%--12% gradient SDS-PAGE and electro-blotted onto nitrocellulose 0.45 μM (GE Healthcare) 100V for 1 h. The membranes were blocked in 5% BSA in TBS-Tween-20 buffer and incubated with pAKT antibody (1:3000) (Cell Signaling) and anti-tubulin (1:10000) (Sigma-Aldrich) overnight at 4°C with constant agitation. The antibody-antigen interaction was visualized by chemiluminescence using HRP-coupled secondary antibody and developed with ECL (Pierce).

Statistics {#sec009}
----------

Statistical significance was calculated using one way ANOVA test. Synapse number comparisons were always performed between experimental conditions *vs* their corresponding control in each experiment. Female larvae were used throughout unless otherwise indicated. Data are plotted as whisker diagrams indicating the maximum and minimum values (vertical line), the 25% and 75% values (box) and the median value (horizontal line within the box). An ANOVA test was used also to compare mRNA levels in qPCR assays. The software GraphPad Instat 3 was used throughout. Significant differences between groups were indicated by \*p\<0.05, \*\*p\<0.001 and \*\*\*p\<0.0001.

Results {#sec010}
=======

Synapses were visualized from the presynaptic active zone (AZ) as nc82 immuno-positive spots which identifies the CAST-type protein Brp. These spots are located opposite to glutamate receptors (GluR) \[[@pone.0184238.ref003], [@pone.0184238.ref070]\] ([S1A Fig](#pone.0184238.s001){ref-type="supplementary-material"}). The levels of Brp have been related to the type of neurotransmitter release mechanism, spontaneous *vs* inducible \[[@pone.0184238.ref071]\]. In our study we do not make a distinction between these two types of AZs. A 3D reconstruction of a normal A3 NMJ is shown in [S1 Movie](#pone.0184238.s007){ref-type="supplementary-material"}. Using the binary UAS/Gal4 expression system \[[@pone.0184238.ref064]\], we manipulated genetically the motor neuron that innervates muscles 6/7 of the larval abdominal segment A3. For brevity, the symbols ↓ and ↑ are used to indicate elicited down- and over-expression, respectively. Genotypes are indicated in the figure legends and synapse number raw data are shown in [S2 Table](#pone.0184238.s005){ref-type="supplementary-material"}.

Receptors and ligands in the pro-synaptogenesis pathway {#sec011}
-------------------------------------------------------

The receptor Wit and its ligand Gbb modulate the number of boutons and their growth \[[@pone.0184238.ref072]--[@pone.0184238.ref074]\]. Boutons and synapses, however, are two different neuronal processes which are not causally related (see below). Thus, we assayed here the potential relationship of PI3K with Gbb and Wit in the context of synaptogenesis.

The ligand Gbb is expressed in, and secreted from, the muscle \[[@pone.0184238.ref059], [@pone.0184238.ref075]\]. The selective over-expression of Gbb in the muscle (*Mhc-Gal4*) had no effect on the number of AZ in the genetically normal presynaptic motor neuron (Gbb↑, [Fig 1A](#pone.0184238.g001){ref-type="fig"}). This lack of effect may reflect a down-titration of the excess of Gbb by Crimpy \[[@pone.0184238.ref073], [@pone.0184238.ref076]\] although we did not explore this possibility further. The *gbb* attenuation by an RNAi (Gbb↓), however, reduces AZ number ([Fig 1A](#pone.0184238.g001){ref-type="fig"}). Heterozygous mutant larvae for *gbb* exhibit a mild reduction of synapses ([Fig 1B](#pone.0184238.g001){ref-type="fig"}). The homozygous mutants are lethal before LIII stage, preventing synapse counting. In the very few *gbb*^*1*^*/gbb*^*2*^ larvae that could be obtained, the number of AZ was 30% reduced (Gbb↓↓) ([Fig 1B](#pone.0184238.g001){ref-type="fig"}). The relatively mild reduction of synapses, even in the homozygotes, suggests that Gbb is not the only ligand, or Wit is not the only receptor, for synaptogenesis (see below and [Discussion](#sec016){ref-type="sec"}). The up-regulation of PI3K in the motor neuron suppresses these *gbb* phenotypes, including the poor viability of the hetero-allelic combination ([Fig 1B](#pone.0184238.g001){ref-type="fig"}). This suppression places PI3K functionally down-stream from Gbb. We also tested a constitutively active form of PI3K, PI3K\*, which rescued the viability trait of the homozygous *gbb* mutants ([Fig 1B](#pone.0184238.g001){ref-type="fig"}). The synapse reduction trait, however, was not fully rescued, perhaps due to the relatively minor pro-synaptogenesis effect of the PI3K\* construct itself. This difference between PI3K and PI3K\* constructs could result from their relative levels of expression due to their chromosomal sites of insertion, and/or stability of the proteins, among other reasons. Nevertheless, PI3K\* proved more effective in the rescue of the mutant genotype of the canonical Gbb receptor, Wit (see below and [Discussion](#sec016){ref-type="sec"}).

![Ligand and receptor of the pro-synaptogenesis pathway.\
**A)** The over- (↑) or down-expression (↓) of the ligand Gbb in the muscle elicits mild changes in the number of synapses as indicated by the number of active zones (AZ) viewed as nc82 spots. Genotypes: **+** = *Mhc-Gal4/+*. **Gbb↑** = *Mhc-Gal4/+;UAS-gbb/+*. **Gbb↓** = *Mhc-Gal4/+;UAS-gbb*^*RNAi*^*/+*. **B)** The *gbb* mutant larvae, either in heterozygous (Gbb↓) or homozygous (Gbb↓↓) conditions show reduced number of synapses. These data support a role of this ligand in synaptogenesis. Note, however, that synapses have not been eliminated (see main text). The viability of homozygotes is very poor and only two LIII larvae could be obtained. This is evidence that Gbb plays additional developmental roles beyond synaptogenesis. The up-regulation of the native form of PI3K suppresses the synapse effect in the heterozygotes although the effect of PI3K on its own is somewhat reduced (compare with PI3K**↑** in panel C). The constitutively active PI3K, PI3K\*, improves the viability of the homozygous *gbb* null mutants but the mutant synapse number is only weakly recovered, and it remains clearly below normal (see main text). Genotypes: + = *D42-Gal4/+*. **Gbb↓** = *gbb*^*1*^/+*; D42-Gal4/+*. **Gbb↓↓** = *gbb*^*1*^*/gbb*^*2*^*; D42-Gal4/+*. **PI3K↑Gbb↓** = *UAS-PI3K*/*gbb*^*1*^; *D42-Gal4/+*. **PI3K\*↑** = *UAS-PI3K\*/+; D42-Gal4/+*. **PI3K\*↑ Gbb↓↓ =** *UAS-PI3K\*/+; gbb*^*1*^*/gbb*^*2*^*; D42-Gal4/+*. **C)** The up-regulation of the native form of PI3K (PI3K↑) increases the number of synapses while its down-regulation (PI3K**↓**) yields the opposite effect. The overexpression of the receptor Wit is ineffective for synapse formation while the mutant condition (Wit**↓↓)** strongly reduces synapses. Note, however, that neither Wit nor Gbb depletion can eliminate synapses fully. Combinations of Wit and PI3K show that the mutant condition for Wit prevails over the overexpression of PI3K suggesting that PI3K requires activation by Wit. Consistent with this notion, the downregulation of PI3K still maintains its phenotype of reduced synapse number even though Wit is over-expressed. In the same line, a constitutively active form of PI3K, PI3K\*, suppresses the mutant condition for the receptor. These results support the conclusion that PI3K is functionally downstream from the receptor Wit. Genotypes: **+** *= D42-Gal4/+* pooled with *OK6-Gal4/+*. **PI3K↑** = *UAS-PI3K/+*; *D42-Gal4/+*. **PI3K***↓* = *UAS-PI3K*^*DN*^*/+; D42-Gal4/+*. **Wit↓↓** = *OK6-Gal4/+; wit*^*A12*^*/wit*^*B11*^. **PI3K↑Wit↓↓** = *OK6-Gal4/UAS-PI3K*; *wit*^*A12*^*/wit*^*B11*^. **Wit↑** = *D42-Gal4/UAS-Wit*. **PI3K↓Wit↑** = *UAS-PI3K*^*DN*^*/+; D42-Gal4/UAS-Wit*. **PI3K\*↑Wit↓↓** = *UAS-PI3K\*/+; OK6-Gal4/+; wit*^*A12*^*/wit*^*B11*^. **D-F)** Representative images of motor neuron 6--7 from larval abdominal segment A3 in normal (+) (**D**), *wit*^*A12*^*/wit*^*B11*^ (↓) (**E**) and *D42-Gal4\>UAS-PI3K* (↑) (**F**) genotypes. Number of NMJ analyzed in independent larvae is indicated in parenthesis adjacent to the genotype. Bar in **F** = 10μm.](pone.0184238.g001){#pone.0184238.g001}

The receptor Wit is a key player for neuromuscular junction (NMJ) development \[[@pone.0184238.ref053], [@pone.0184238.ref056]\]. Eliminating its expression (hetero-allelic combination *wit*^*A12*^*/wit*^*B11*^) results in decrease of AZ numbers (Wit↓↓, [Fig 1C](#pone.0184238.g001){ref-type="fig"}). This effect supports the role of Wit as a key receptor in synaptogenesis. The co-expression of PI3K↑ yields the phenotype of Wit↓↓ alone, but a constitutive active form of PI3K, PI3K\*, can suppress the Wit↓↓ phenotype ([Fig 1C](#pone.0184238.g001){ref-type="fig"}). On the other hand, the over-expression of Wit is ineffective to change AZ numbers and the co-downexpression with PI3K results in the phenotype of PI3K↓ alone ([Fig 1C](#pone.0184238.g001){ref-type="fig"}). All these data indicate that PI3K is functionally downstream from Wit and requires its activation by the receptor.

The functional link of PI3K with Wit, considered as a receptor Ser/Thr kinase type (RSTK), appears unusual, since PI3K is more often related to receptors of the Tyr kinase type (RTK) (see [Discussion](#sec016){ref-type="sec"}). To further look into this issue, we tested classical RTKs in the context of synaptogenesis ([S1 Table](#pone.0184238.s004){ref-type="supplementary-material"}). No changes in AZ numbers were observed, underlying the specificity of Wit in neurons. In particular, the lack of effect of Thick veins (Tkv) and Saxophone (Sax), either separately or in combination, indicates that, contrary to NMJ development or growth \[[@pone.0184238.ref072]\], the role of Wit to signal for synaptogenesis does not rely on Tkv or Sax heterodimers. Among the tested RTKs, we included Torso which is not normally expressed in motor neurons. This ectopic expression was also ineffective to elicit synaptogenesis which further underlies the specificity of PI3K activation by the receptor Wit in the context of synaptogenesis.

Signaling from virtually all RTK pathways debouch in the relive of target gene silencing imposed by the transcriptional repressor Capicua (CIC) which is degraded \[[@pone.0184238.ref077]\]. We reasoned that, if Wit signals through a RTK pathway, then an increase of CIC levels should mimic the effects of Wit↓. Driving *UAS-cic* to motor neurons (*Gal4-D42*) caused a severe reduction of the number of synapses almost identical to that of Wit↓ ([S1B Fig](#pone.0184238.s001){ref-type="supplementary-material"}). These results open the possibility that Wit could elicit several modes of signaling depending on binding ligand or oligomerization partner (see [Discussion](#sec016){ref-type="sec"}).

Representative images of NMJs showing normal (+), increased (↑) and decreased (↓) AZ numbers illustrate how bouton number, or bouton size, do not correlate with synapse number **(**[Fig 1D--1F](#pone.0184238.g001){ref-type="fig"}, see also [S1 Movie](#pone.0184238.s007){ref-type="supplementary-material"} to illustrate AZs outside boutons and boutons without AZs). This is one, among several others (see below), argument that justify the need to count synapses directly rather than using bouton number as a surrogate to evaluate synapse number changes (see [Materials and methods](#sec002){ref-type="sec"}).

Two other RTKs were also investigated due to their postsynaptic (muscle) localization, Heartless (Htl) and Breathless (Btl) \[[@pone.0184238.ref078]--[@pone.0184238.ref080]\]. Mutant heterozygotes for each of these two FGFR-like receptors show a significant increase in the number of synapses ([S1C Fig](#pone.0184238.s001){ref-type="supplementary-material"}), indicating that they play a role in synaptogenesis. Thus, we tested the possible involvement of Htl and Btl on *gbb* expression by qPCR assays. The reduction of Htl (heterozygous *htl*^*AB42*^*/+*) increased *gbb* transcription while that of Btl (heterozygous *btl*^*dev1*^*/+*) led to the opposite effect ([S2A Fig](#pone.0184238.s002){ref-type="supplementary-material"}), suggesting that the two receptors regulate Gbb levels through antagonistic signaling within the muscle. To test if there could be a reverse, neuron-to-muscle, signaling to regulate *gbb*, we carried out additional qPCR assays in larvae with neuronal (*elav-Gal4*) up- or down-expression of PI3K. No transcriptional changes in *gbb* were detected in these larvae ([S2A Fig](#pone.0184238.s002){ref-type="supplementary-material"}). Thus, the reported activity of Gbb in neurons is not functionally related to PI3K levels. Our data are consistent with the proposal of two distinct pools of Gbb to control synapse structure and function, respectively \[[@pone.0184238.ref076]\].

In addition, we assayed the transcriptional expression of the known ligands of Htl and Btl; Pyramus (Pyr), Thisbe (Ths) and Branchless (Bnl), respectively \[[@pone.0184238.ref081]--[@pone.0184238.ref084]\] ([S2B--S2D Fig](#pone.0184238.s002){ref-type="supplementary-material"}). No effect on the expression of these ligands was observed when PI3K was altered in neurons; which is consistent with the muscular origin of Gbb signaling for synaptogenesis. So far, the data show that, once Gbb is secreted from the muscle and synaptogenesis is triggered in the motor neuron, no feed-back signaling is elicited. That is, once initiated, synaptogenesis proceeds autonomously in the motor neuron. Synapse activity, however, may require Gbb mediated coordination from the postsynaptic side as proposed \[[@pone.0184238.ref076]\]. Retrograde signaling has been reported in activity dependent modulation of synapses where it is mediated by BMP \[[@pone.0184238.ref085]\]. Here, we focus on synapse formation rather than on activity.

Pro-synaptogenesis signaling downstream from the receptor {#sec012}
---------------------------------------------------------

Since, in addition to tyrosine-kinase, G-protein coupled receptors can activate PI3K, and the small GTPase Ras has been implicated in vertebrate synaptogenesis \[[@pone.0184238.ref086]\], we tested its *Drosophila* homolog, Ras85D, in the Wit/PI3K signaling context. In the first series of experiments, neither the overexpression of Ras85D nor its downregulation by a dominant negative form, Ras85D^DN^, revealed any effect on synapse number ([Fig 2A](#pone.0184238.g002){ref-type="fig"}). Also, co-manipulation of Ras85D and Wit in either direction or combination failed to show synapse number effects. Although these data could be taken as evidence that Ras85D does not play a role in *Drosophila* synaptogenesis, in contrast to vertebrates, the subsequent series of experiments with PI3K proved the opposite.

![Signaling factors downstream from the receptor Wit.\
**A)** The over- or down-expression of Ras85D, either alone or in combination with manipulations of Wit, seem ineffective to change synapse number. Further experiments, however, proved the contrary (see below). Genotypes: **+** = *D42-Gal4/+*. **Ras85D↑** = *UAS-Ras85D/+*; *D42-Gal4/+*. **Ras85D↑Wit↓** = *UAS-Ras85D/+*; *D42-Gal4/UAS-Wit*^*RNAi*^. **Ras85D↓** = *UAS-Ras85D*^*DN*^*/+; +/+; D42-Gal4/+*. **Ras85D↓Wit↑** = *UAS-Ras85D*^*DN*^*/+; UAS-Wit /+; D42-Gal4/+*. **Ras85D↑Wit↑** = *UAS-Wit/UAS-Ras85D; D42-Gal4/+*. **B**) PI3K-Ras85D interactions. Both, the over- or down-expression of Ras85D, which seemed ineffective on the synapse number, suppress the synapse increase due to PI3K↑ when jointly expressed. In the case of Ras85D↓ the phenotype is converted into synapse decrease. These features demonstrate that Ras85D is functionally related to PI3K in the context of synaptogenesis. The up-regulation of a PI3K form that is deleted in the Ras phosphorylation site, *myc-PI3K*^ΔRBD^, is still able of increase synapses even though its control, *myc-PI3K*, is somewhat less effective than PI3K. The *PI3K*^ΔRBD^ form, as the normal PI3K, transforms the Ras85D↓ phenotype into a severe synapse reduction. These data are consistent with Ras85D being functionally located somewhere down stream in the PI3K pathway. Genotypes: **+** = *D42-Gal4/+*. **PI3K↑** = *UAS-PI3K/+; D42-Gal4/+*. **PI3K↑Ras85D↑ =** *UAS-Ras85D/+; UAS-PI3K/+; D42-Gal4/+*. **PI3K↑Ras85D↓** = *UAS-Ras85D*^*DN*^*/+; UAS-PI3K/+; D42-Gal4/+*. **myc-PI3K↑** = *D42-Gal4/UAS-myc-Dp110*. **myc-PI3K**^**ΔRBD**^**↑** = *D42-Gal4/UAS-myc-Dp110*^*RBD*^. **myc-PI3K**^**ΔRBD**^**↑Ras85D↓** = *UAS-Ras85D*^*DN*^*/+; D42-Gal4/UAS-myc-Dp110*^*RBD*^. **C)** Western blot analysis (triplicates) of phospho-AKT relative levels under Ras85D overexpression. No increase of pAKT is detected demonstrating that Ras85D is functionally downstream from AKT. Genotypes: **+** = *D42-Gal4/+*. **Ras85D↑** = *UAS-Ras85D/+*; *D42-Gal4/+*.](pone.0184238.g002){#pone.0184238.g002}

The simultaneous up-regulation of Ras85D and PI3K suppressed the synapse number increase due to PI3K alone ([Fig 2B](#pone.0184238.g002){ref-type="fig"}). This result demonstrates that the *UAS-Ras85D* construct is effective and that both proteins are functionally linked in the context of synaptogenesis. Furthermore, the *UAS-Ras85D*^*DN*^ construct (Ras85D↓) is also effective because it transforms the synapse increase due to PI3K↑ into a significant decrease ([Fig 2B](#pone.0184238.g002){ref-type="fig"}). Thus, consistent with vertebrates, *Drosophila* Ras85D is also involved in synaptogenesis, and we can add that it acts by counteracting the role of PI3K. Since, in certain pathways, PI3K needs Ras binding for maximal activity \[[@pone.0184238.ref045]\], we considered PI3K as a potential site of convergence with Ras85D in the context of synaptogenesis. To determine if the Ras85D requirement occurs at the PI3K step, we tested a form of PI3K in which the Ras binding site is deleted, PI3K^ΔRBD^. This myc-tagged PI3K^ΔRBD^ form elicited a synapse increase equivalent to that of the normal PI3K (myc-PI3K) demonstrating that Ras binding is dispensable for PI3K activity in this context ([Fig 2B](#pone.0184238.g002){ref-type="fig"}). Consistent with the functional link between Ras85D and PI3K, the down regulation of Ras85D did suppress the pro-synaptic effect of PI3K^ΔRBD^ yielding a strong decrease ([Fig 2B](#pone.0184238.g002){ref-type="fig"}).

As a further attempt to locate Ras85D in the signaling hierarchy, we tested by Western blot the relative levels of phospho-AKT in flies over-expressing Ras85D \[[@pone.0184238.ref087]\]. The data show that the mechanism of Ras85D activity does not involve an increase of p-AKT levels ([Fig 2C](#pone.0184238.g002){ref-type="fig"}). Therefore, we can conclude that, contrary to other signaling contexts, PI3K-Ras85D binding is not a requirement in synaptogenesis, placing the role of Ras85D in synaptogenesis further down along the pathway.

Intermediate signaling in the pro-synaptogenesis pathway {#sec013}
--------------------------------------------------------

Highwire (Hiw) has been reported as a negative regulator of NMJ growth in *Drosophila* \[[@pone.0184238.ref050], [@pone.0184238.ref059]\] and *C*. *elegans* \[[@pone.0184238.ref088]\]. This interpretation is based on the observation that *Hiw* mutants in both species show overgrown NMJs. Hiw has, at least, two different substrates: Wallenda, the first MAPK of the JNK cascade \[[@pone.0184238.ref050]\], and the transcriptional factor Medea \[[@pone.0184238.ref044], [@pone.0184238.ref089]\]. We tested the involvement of PI3K in the Hiw-MAPK signaling ([Fig 3A](#pone.0184238.g003){ref-type="fig"}).

![Intermediate signaling in the pro-synaptogenesis pathway.\
**A**) Interactions between Hiw and PI3K. The overexpression (Hiw↑) increases the number of synapses, while the mutant *hiw*^*ND8*^ or a form deleted in the E3 domain, Hiw^ΔE3^, show a non-significant tendency towards reduction only. However, while the over-expression of PI3K (PI3K↑) increases the number of synapses and its downregulation with a dominant negative form (PI3K↓) reduces it, both effects are suppressed by manipulating Hiw in the opposite directions. These data place Hiw functionally downstream from PI3K in the pathway. Genotypes: **+** = *D42-Gal4/+*. **Hiw↑** = *UAS-Hiw/+; D42-Gal4/+*. **Hiw***↓* = males *hiw*^*ND8*^*; +/+; D42-Gal4/+*. **Hiw**^**ΔE3**^**↑** = *D42-Gal4/UAS-NT-Hiw*^*ΔRING*^. **PI3K↑** = *UAS-PI3K/+; D42-Gal4/+*. **PI3K***↓* = *UAS-PI3K*^*DN*^*/+; D42-Gal4/+*. **PI3K***↓***Hiw↑** = *UAS-Hiw/UAS-PI3K*^*DN*^*; D42-Gal4/+*. **PI3K↑Hiw***↓* = males *hiw*^*ND8*^*; UAS-PI3K/+; D42-Gal4/+*. **B**) The MAPKs of the pathway. Wnd shows the expected pro-synaptogenesis effect while Hep fails to reach statistical significance. However, their target, Bsk/JNK, does show the expected synapse increase. Apparently, the Bsk↓ construct is ineffective and there is no evidence of synergy or antagonism with PI3K in the PI3K↑Bsk↑ or PI3K↑ Bsk↓ conditions (however, see below). Genotypes: **+** = *D42-Gal4/+*. **Wnd↑** = *UAS-Wnd/+; D42-Gal4/+*. **Hep↑** = *UAS-Hep/+; D42-Gal4/+*. **Bsk↑** = *UAS-Bsk/+; D42-Gal4/+*. **Bsk↓** = *D42-Gal4/UAS-Bsk*^*DN*^. **PI3K↑Bsk↑** = *UAS-Bsk/UAS-PI3K; D42-Gal4/+*. **PI3K↑Bsk↓** = *UAS-PI3K/+; D42-Gal4/UAS-Bsk*^*DN*^. **C)** The possible regulation of Bsk by Ras85D. Although the up-regulation of Bsk had proven pro-synaptogenic, its concomitant over-expression with the seemingly ineffective Ras85D transforms the pro- into an anti-synaptogenesis effect. Also, the apparently ineffective Ras85D↓ suppresses the pro-synaptogenic effect of Bsk↑. These data are indicative of a regulatory interaction between Ras85D and Bsk. The Bsk↓ condition, which proved ineffective, remained unchanged irrespective of the two possible alterations of Ras85D. Genotypes: **+** = *D42-Gal4/+*. **Bsk↑Ras**^**85D**^**↑** = *UAS-Bsk/UAS-Ras85D; D42-Gal4/+*. **Bsk↑Ras**^**85D**^**↓** = *UAS-Ras85D*^*DN*^*/+; UAS-Bsk/+; D42-Gal4/+*. **Bsk↓Ras**^**85D**^**↑** = *UAS-Ras85D/+; D42-Gal4/UAS-Bsk*^*DN*^. **Bsk↓Ras**^**85D**^**↓** = *UAS-Ras85D*^*DN*^*/+; +/+; D42-Gal4/UAS-Bsk*^*DN*^. **D)** The Bsk regulator Puc and the convergence with Ras85D in a tripartite interaction. Whereas the downregulation of Puc or Bsk separately yields no effect on synaptogenesis, their joint co-downregulation results in a strong decrease of the number of synapses. Also, the synapse increase elicited by Bsk↑ is rendered non-significant because of the wide dispersion of values elicited by the joint down regulation of Puc. The two triple combinations tested result in a notable reduction of the variability in the number of synapses (see text). Together, the data in **C** and **D** reveal a complex regulatory network at the final step of the MAPK cascade. Genotypes: **+** = *D42-Gal4/+*. **Puc↓** = *UAS-puc*^*RNAi*^/+; *D42-Gal4/+*. **Puc↓Bsk↓** = *UAS-puc*^*RNAi*^/*+; D42-Gal4/UAS-Bsk*^*DN*^. **Puc↓Bsk↑** = *UAS-Bsk/UAS-puc*^*RNAi*^*; D42-Gal4/+*. **Puc↓Bsk↑Ras**^**85D**^**↓** = *UAS-Ras85D*^*DN*^*/+; UAS-puc*^*RNAi*^/*UAS-Bsk; D42-Gal4/+*. **Puc↓Bsk↓Ras**^**85D**^**↑** = *UAS-Ras85D*, *UAS-puc*^*RNAi*^*/+; D42-Gal4/ UAS-Bsk*^*DN*^.](pone.0184238.g003){#pone.0184238.g003}

As expected, the Hiw↑ condition increased significantly the number of synapses. The loss-of-function allele *Hiw*^*ND8*^ (Hiw↓) or the overexpression of a form deleted in the E3 ubiquitin ligase domain, *Hiw*^*Δ3*^, yielded only a trend towards synapse number reduction that failed to reach statistical significance ([Fig 3A](#pone.0184238.g003){ref-type="fig"}). However, as in the case of Ras85D above, the phenotypic effects of the loss-of-function condition for Hiw became evident when tested in combinations with PI3K. The co-expression of Hiw↑ and PI3K↓ results in the mutual suppression of the single phenotypes and yields normal number of synapses ([Fig 3A](#pone.0184238.g003){ref-type="fig"}). The opposite combination, Hiw↓PI3K↑, transforms the PI3K↑ into a significant reduction of synapse number; thus, revealing the expected effect of Hiw↓ ([Fig 3A](#pone.0184238.g003){ref-type="fig"}). A further evidence of the Hiw-PI3K interaction is reflected in the synergy of the Hiw↓PI3K↓ combination which results in lethality earlier than the third larval instar. This feature prevented synapse counting. Taken together, these results are consistent with the functional location of Hiw downstream from PI3K. Interestingly, the *Hiw*^*ND8*^ mutant exhibited the reported increase in branch length \[[@pone.0184238.ref055], [@pone.0184238.ref060]\], which contrasts with the lack of effect on synapse number ([S3 Table](#pone.0184238.s006){ref-type="supplementary-material"}). This is another example illustrating the independence of neuritogenesis with respect to synaptogenesis. The case of Hiw is also in line with a previous report on LIMK1 which binds the Wit receptor to promote synapse stability, but the binding is dispensable for synapse growth or function \[[@pone.0184238.ref090]\].

The *Drosophila* MAPKs *Wallenda (Wnd)*, *Hemipterous (Hep)* and *Basket (bsk)* are homologues of vertebrate DLK (MAPK), MKK7 (MAPKK) and JNK (MAPKKK), respectively. Their role in synaptogenesis and their relationship with Hiw are relatively well established \[[@pone.0184238.ref050]\], albeit complex. The context-dependence of the Hiw-MAPKs signaling is illustrated by the recently reported cell autonomous and non-cell autonomous effects of Hiw. Whereas Hiw attenuates Wnd, Bsk and the transcription factor Jun (see below) in the neuron, in glial cells, the transcriptional output of Hiw seems to be through Fos, which acts on adjacent neurons via an unidentified secreted factor \[[@pone.0184238.ref091]\]. Here, we confirmed most of the expected MAPK effects in the NMJ with increases in synapse number after Wnd and Bsk upregulations ([Fig 3B](#pone.0184238.g003){ref-type="fig"}).

In the case of Hep, its upregulation does not seem to produce the expected synapse increase ([Fig 3B](#pone.0184238.g003){ref-type="fig"}). The homologue in vertebrates, MKK7, cooperates with MKK4 to activate JNK/Bsk \[[@pone.0184238.ref092]\]. This cooperative effect is non-redundant and it exhibits a wide repertoire of context-dependent signaling properties \[[@pone.0184238.ref093]\]. Thus, it is plausible that the fly Hep would require a MKK4 equivalent to display its synaptogenesis effects. On the issue of neuritogenesis *versus* synaptogenesis (see above), it is worth noting that Wnd↑ and Hep↑ yielded the reported branch overgrowth ([S3A--S3C Fig](#pone.0184238.s003){ref-type="supplementary-material"}) \[[@pone.0184238.ref049], [@pone.0184238.ref050]\], but synapses were increased in Wnd↑ only. Likewise, Hiw↓ increased branching ([S3D Fig](#pone.0184238.s003){ref-type="supplementary-material"}**),** but not synapses. This suggests that neurito- and synaptogenesis share some signaling steps while they keep others as specific.

Concerning Bsk, the ↑ condition yielded the expected synapse increase but the ↓ condition seemed ineffective ([Fig 3B](#pone.0184238.g003){ref-type="fig"}). However, as in previous cases, Bsk↓ revealed its effect on synaptogenesis when combined with other regulatory elements of the pathway. The joint up-regulation of PI3K and Bsk, two factors promoting synapse increase, maintain their single phenotypes without evidences of synergy ([Fig 3B](#pone.0184238.g003){ref-type="fig"}). This is consistent with the location of both factors in the same pathway. Further, if Bsk would be down stream of PI3K in a simple functional dependency, one would expect that Bsk↓ would suppress PI3K↑. This double genotype still showed synapse increase, although not as high as PI3K↑ alone ([Fig 3B](#pone.0184238.g003){ref-type="fig"}). This result suggests that the actual output from Bsk is subject to the regulation by additional factors beyond PI3K and the tested MAPKs.

Since we had concluded (see above) that Ras85D is functionally located downstream from PI3K, we considered if Ras85D could contribute to the pathway through a regulatory convergence on Bsk. Thus, we tested the joint ↓ and ↑ conditions for Bsk and Ras85D. The synapse number increase caused by Bsk↑ is transformed into reduction by Ras85D↑ which, by itself, had no effect ([Fig 3C](#pone.0184238.g003){ref-type="fig"}). This transformation of phenotype is suggestive of antagonistic regulation between both enzymatic activities or upon a third substrate. Consistent with this interpretation, the Bsk↑ phenotype is cancelled by Ras85D↓ yielding normal synapse number ([Fig 3C](#pone.0184238.g003){ref-type="fig"}). The other two combinations possible, whose single components had no synaptic effect, remained ineffective ([Fig 3C](#pone.0184238.g003){ref-type="fig"}).

Beyond the novel regulatory role of Ras85D over Bsk proposed here, Bsk has been shown to be regulated also by the phosphatase *puckered* (*puc*) in epithelial cells \[[@pone.0184238.ref094]\]. We tested if the synaptogenic effects of Bsk could be modified by Puc. Although Puc↓ and Bsk↓ had no effect on synapses separately, the double combinations resulted in strong reduction of synapse number, indicating that Puc is also a Bsk regulator in this context ([Fig 3D](#pone.0184238.g003){ref-type="fig"}). As reasoned above, uncovering a phenotype by the combination of two elements which appeared ineffective on their own is an indication that both elements may be part of a binary system of regulation. Furthermore, the seemingly ineffective Puc↓ condition suppresses the effect of Bsk↑ by dispersing the values of synapse number beyond statistical significance ([Fig 3D](#pone.0184238.g003){ref-type="fig"}).

To evaluate if the regulatory roles of Ras85D and Puc over Bsk are independent or redundant, we assayed triple combinations of these constructs. Puc↓ does not modify the suppression that Ras85D↓ plays over Bsk↑ already ([Fig 3C and 3D](#pone.0184238.g003){ref-type="fig"}). Also, Puc↓ does not modify the lack of effects exhibited by Bsk↓ and Ras85D↑, either separately or in combination. Taken together, these data may indicate that Bsk and Ras85D/Puc antagonize each other in the context of synaptogenesis, perhaps by helping to set the normal activity threshold of Bsk. In this way, Bsk activity level is revealed as a particularly sensitive step in the signaling pathway and subject to the dual, but independent, regulation by Puc and Ras85D.

Effectors of the pro-synaptogenesis pathway {#sec014}
-------------------------------------------

AP-1 is a transcriptional complex that includes the heterodimer Jun/Fos \[[@pone.0184238.ref095]\]. It is known to play multiple roles in development and, in conjunction with the MAPK cascade, it is involved in neuronal growth \[[@pone.0184238.ref049], [@pone.0184238.ref096]\] and hence, in neural plasticity and memory \[[@pone.0184238.ref097], [@pone.0184238.ref098]\]. Actually, *puc* seems to modulate target gene expression by antagonizing a Rho GTPase pathway that stabilizes AP-1, perhaps through a kinase-dependent mechanism \[[@pone.0184238.ref099]\].

We tested the relative contributions of Jun and Fos to synaptogenesis. Out of the four genotypes possible, only Jun↑ gave a phenotype, synapse increase, which justifies its qualification as a pro-synaptogenesis element ([Fig 4A](#pone.0184238.g004){ref-type="fig"}). As in the case of Ras85D above, the seemingly ineffective constructs revealed their role when in combination with other elements. The joint overexpression of Jun and Fos maintained the synapse increase due to Jun↑ alone. However, the effect of the later becomes transformed into synapse reduction by the co-expression with the apparently ineffective Fos↓ ([Fig 4A](#pone.0184238.g004){ref-type="fig"}).

![Effectors of the pathway.\
**A)** Epistasis analysis of the AP-1 components, Fos and Jun. Single manipulations of these two transcription factors in either direction yields the expected synapse increase in the case of Jun↑ only, which could be interpreted as if the other three constructs were ineffective. However, Fos↓ transforms the Jun↑ synapse increase effect into a decrease. This and other results throughout this study demonstrate that the seemingly ineffective constructs are functional. Likely, Jun and Fos play their role through interactions with other anti-synaptogenesis transcription factors (see below). Genotypes: **+** = *D42-Gal4/+*. **Jun↑** = *D42-Gal4/UAS-Jun*. **Jun↓** = *UAS-Jun*^*DN*^*/+; D42-Gal4/+*. **Fos↑** = *UAS-Fos/+; D42-Gal4/+*. **Fos↓** = *UAS-Fos*^*DN*^*/+; D42-Gal4/+*. **Jun↑Fos↑** = *UAS-Fos/+; D42-Gal4/ UAS-Jun*. **Jun↓Fos↓** = *UAS-Fos*^*DN*^*/UAS-Jun*^*DN*^*; D42-Gal4/+*. **Jun↑Fos↓** = *UAS-Fos*^*DN*^*/+; D42-Gal4/UAS-Jun*. **B)** The Med-Mad components. The up- or down-regulation of these two transcription factors yield effects consistent with a role as negative regulators of synaptogenesis which implies the existence of an anti-synaptogenesis pathway. Genotypes: **+** = *D42-Gal4/+*. **Medea↑** = *D42-Gal4/UAS-Medea*^*\#5*.*13A3*^. **Medea↓** = *D42-Gal4/UAS-TRiP*.*JF02218attP*. **Mad↑** = *UAS-Mad*^*\#2A2*^*/D42-Gal4/+*. **Mad↓** = *UAS-Mad*^*RNAi*^ */+; D42-Gal4/+*. **C)** Mad interactions with AP-1. The apparently ineffective Jun↓ and Fos↓ constructs suppress the Mad↓ phenotype when jointly expressed. This set of data proves that the constructs are effective and that Fos and Jun interact with the anti-synaptogenesis factor Mad. Genotypes: **+** = *D42-Gal4/+*. **Mad↓Jun↓ =** *UAS-Mad*^*RNAi*^ */UAS-Jun*^*DN*^*; D42-Gal4/+*. **Mad↓Fos↓ =** *UAS-Fos*^*DN*^*/UAS-Mad*^*RNAi*^*; D42-Gal4/+*. **D)** In a separate experiment, hence the reason for a separate panel, two conditions that had shown pro-synaptogenesis effects, Jun↑ and Mad↓, although they still show synapse increase, the magnitude of the effect is lower than each element separately. This is suggestive of an antagonistic interaction between these two transcription factors. Genotypes: **+** = *D42-Gal4/+*. **Jun↑Mad↓ =** *UAS-Mad*^*RNAi*^ */+; D42-Gal4/UAS-Jun*.](pone.0184238.g004){#pone.0184238.g004}

As reasoned for the case of Bsk and Ras85D above, this result with Jun↑Fos↓ suggests a functional antagonism between Jun and Fos in the context of synaptogenesis, as if the two components of the AP-1 complex would counterbalance each other. The role of Fos as transcriptional activator has been shown to be context dependent, in particular the context provided by Jun and Mad \[[@pone.0184238.ref100]\] (see also below on the synaptic effects of Mad). If the regulation of AP-1 stability by Puc and a Rho GTPase turns out to be effective in the context of synaptogenesis as proposed \[[@pone.0184238.ref099]\], it is likely that revealing synapse phenotypes would require joint manipulations of several of these components.

Anti- and pro-synaptogenesis pathways and their interactions {#sec015}
------------------------------------------------------------

The reported inhibition of Medea (Med) by Hiw \[[@pone.0184238.ref059]\] and the differential activity of Jun prompted us to analyze the effect of Med transcription factor and its partner, Mothers-against-dpp (Mad/Mnt), in the context of synaptogenesis. Interestingly, both factors exhibited coherent anti-synaptogenesis phenotypes. That is, decrease of synapse number in the ↑ condition and increase of synapses in the ↓ condition ([Fig 4B](#pone.0184238.g004){ref-type="fig"}). Mad and Med are known for their role in preventing cell differentiation to promote proliferation \[[@pone.0184238.ref101]\]. Here, they seem to reveal an anti-synaptogenesis signaling pathway without proliferation effects, given that axon numbers in the NMJ remained normal in these genotypes. Since transcription factors with putative pro- and anti-synaptogenesis roles had been identified, we explored the joint effects of some of them. The apparently ineffective Jun↓ condition suppressed the Mad↓ phenotype ([Fig 4C](#pone.0184238.g004){ref-type="fig"}). This result is relevant because it proves that the Jun↓ construct is functional (see above). Likewise, the Fos↓ condition suppressed the Mad↓ phenotype ([Fig 4C](#pone.0184238.g004){ref-type="fig"}). Also, the combination of two factors that yield synapse increase separately, Jun↑ and Mad↓ ([Fig 4A and 4B](#pone.0184238.g004){ref-type="fig"}) produced a synapse increase greatly attenuated with respect to the separate factors ([Fig 4D](#pone.0184238.g004){ref-type="fig"}). These data represent evidence that AP-1, either as a Jun/Fos heterodimer or as independent components, and Mad functionally interact in the context of synaptogenesis in an antagonistic manner.

The canonical signaling pathway of Mad/Med includes the transcriptional co-regulator Yorkie and the microRNA bantam \[[@pone.0184238.ref102]\]. Thus, we tested bantam (Ban) in the context of synaptogenesis. The Ban↑ condition elicited a wide dispersion of synapse number values that render the tendency towards reduction as non-statistically significant. However, that condition suppressed the effects of PI3K↑, Hiw↑ and Ras85D↑ when jointly expressed ([Fig 5A](#pone.0184238.g005){ref-type="fig"}). In addition, the apparently ineffective Ban↑ transformed the phenotypes of Bsk↑ and Bsk↓ ([Fig 3B](#pone.0184238.g003){ref-type="fig"}) into a synapse reduction ([Fig 5A](#pone.0184238.g005){ref-type="fig"}). These data justified the allocation of Ban to the anti-synaptogenesis pathway and revealed its downregulation effects upon several elements of the pro-synaptogenesis pathway with the notable exception of Akt↑. The case of Akt is indicative that Ban does not target that gene and, in addition, that Akt has a substrate functionally downstream of Ban (see below). Thus, bantam should be included in the long list of microRNAs which contribute to synapse control \[[@pone.0184238.ref103]\].

![The anti-synaptogenesis pathway.\
**A**) The microRNA bantam shows a tendency towards synapse reduction which becomes evident by suppressing the synapse increase of PI3K↑, Hiw↑ and Bsk↑. By contrast, AKT escapes the repression by Ban since it maintains its synapse increase phenotype reported previously. Although below statistical significance, the pro-synaptogenesis tendency exhibited by Ras85D↑ seems also reverted by Ban. Also, the apparently ineffective Bsk↓ or the pro-synaptogenesis Bsk↑, both become anti-synaptogenic by Ban. These data justify the inclusion of Ban in the anti-synaptogenesis pathway and indicate additional targets for this microRNA. Genotypes: **+** = *D42-Gal4/+*. **Ban↑** = *D42-Gal4/UAS-bantam*. **Ban↑PI3K↑** = *UAS-PI3K/+; D42-Gal4/UAS-bantam*. **Ban↑Hiw↑** = *UAS-Hiw/+; D42-Gal4/UAS-bantam*. **Ban↑Ras85D↑** = *UAS-Ras85D/+; D42-Gal4/UAS-bantam*. **Ban↑AKT↑** = *D42-Gal4/UAS-bantam*,*UAS-Akt*. **Ban↑Bsk↑** = *UAS-Bsk/+; D42-Gal4/UAS-bantam*. **Ban↑Bsk↓** = *UAS-Bsk*^*DN*^*/+; +/+; D42-Gal4/UAS-bantam*. **B)** Assays of selected MAPK and GTPases candidates for the anti-synaptogenesis signaling. Genotypes: **+** = *D42-Gal4/+*. **Put↓** = *UAS-put*^*RNAi*^*/+; D42-Gal4/+*. **Rala↓** = *UAS-Rala*^*DN*^*/+; D42-Gal4/+*. **Slpr↓** = *D42-Gal4/UAS-Slpr*^*RNAi*^. **Lic↑** = *UAS-Lic/+; +/+; D42-Gal4/+*. **p38↓** = *UAS-p38a*^*RNAi*^*/+; D42-Gal4/+*. **Ras64B↑** = *UAS-Ras64B*^*V14*^*/+; D42-Gal4/+*. **Ask1↓** = *D42-Gal4/UAS-Ask1*^*RNAi*^. **AKT↑Mad↑** = *UAS-Akt/+; +/+; D42-Gal4/UAS-Mad*^*\#2A2*^.](pone.0184238.g005){#pone.0184238.g005}

The identification of transcriptional regulators with anti-synaptogenesis effects implies a corresponding signaling pathway that would counteract the pro-synaptogenesis pathway described hereto. Thus, we explored candidate genes that encode proteins akin to those constituting the pro-synaptogenesis signaling, MAPK and GTPases, mainly. The candidate genes were chosen based on previous reports of their functional interactions with *yorkie* (*yki*), a canonical member of the Mad/Medea transcriptional complex \[[@pone.0184238.ref104]\]. Out of the seven candidates tested, the two small GTPases Ras-like-a (Rala) and Ras64B (Ras64B), along with the two MAPKs Licorne (Lic) and p38a yielded synaptic phenotypes compatible with their adscription to the anti-synaptogenesis pathway ([Fig 5B](#pone.0184238.g005){ref-type="fig"}). Testing Licorne and p38a was justified because these two kinases share the same pathway in other cellular contexts \[[@pone.0184238.ref105], [@pone.0184238.ref106]\]. Here, p38 seems to contribute to the anti-synaptogenesis signaling while data on Licorne are too variable to draw a conclusion ([Fig 5B](#pone.0184238.g005){ref-type="fig"}). Concerning Rala, this neural GTPase plays a role in the activity-dependent changes at the postsynaptic side \[[@pone.0184238.ref107]\]. Thus, it seems coherent that, down-regulating it in the presynaptic side would increase synapse number. By contrast, the tyrosine kinase receptor punt (Put), the protein kinases Slipper (Slpr) and the apoptotic signaling-1 (Ask1/Pk92B) caused no effect ([Fig 5B](#pone.0184238.g005){ref-type="fig"}). The lack of effect of Ask1 represents another example of a context-dependent specificity for signaling. In human islet cells, Ask1 is functionally related to PI3K and JNK signaling \[[@pone.0184238.ref108]\], but it does not seems to be the case for synaptogenesis in fly neurons. Remarkably, all these anti-synaptogenesis components belong to the same functional classes (small GTPases, MAPK, etc.) as those of the pro-synaptogenesis pathway (see [Discussion](#sec016){ref-type="sec"}). The Yki transcriptional cofactor is known to receive signaling through the Hippo-Salvador-Warts pathway \[[@pone.0184238.ref109]\]. An alternative Hippo pathway has been reported that does not use Yki as a transcriptional effector and that, remarkably, mediates neuronal bouton formation \[[@pone.0184238.ref110]\]. This is another evidence of the strong context-dependence of signaling pathways.

Finally, the substrate for Akt downstream from Ban that we hypothesized above was tested in the double genotype with Mad, the final effector of the anti-synaptogenesis pathway. Both elements together, Akt↑Mad↑, cancelled each other yielding a normal number of synapses ([Fig 5B](#pone.0184238.g005){ref-type="fig"}). This result is consistent with the observed lack of suppression of Akt↑ by Ban ([Fig 5A](#pone.0184238.g005){ref-type="fig"}) and suggests that Mad may be targeted by Akt in the context of synaptogenesis. The results in this report compose a scenario in which a delicate signaling balance between two antagonistic pathways determines the number of synapses that a neuron will establish under a particular functional status ([Fig 6](#pone.0184238.g006){ref-type="fig"}).

![Summary diagram of antagonistic signaling pathways for synaptogenesis and their interactions.\
The pro-synaptogenesis pathway is shown in green while the anti-synaptogenesis one is shown in red. Arrows indicate activation and blunt lines indicate repression. Full lines correspond to interactions tested in this study and dotted lines refer to studies in other cellular contexts. The factor Yki was not included in this study and it is shown to illustrate interactions reported with the anti-synaptogenesis factors tested here. The vertebrate orthologues are shown between parentheses.](pone.0184238.g006){#pone.0184238.g006}

Discussion {#sec016}
==========

The epistasis assays have determined the *in vivo* functional links between PI3K and other previously known pro-synaptogenesis factors. Epistasis assays are based on the combined expression of two or more UAS constructs. Several double combinations in this study have produced a phenotype in spite of the apparent ineffectiveness of the single constructs. This type of results underscores the necessity to use epistasis assays in order to reveal functional interactions in vivo, hence, biologically relevant. In addition to the pro-synaptogenesis signaling, the study has revealed an anti-synaptogenesis pathway that composes a signaling equilibrium to determine the actual number of synapses. The magnitude of the synapse number changes elicited by the factors tested here are mostly within the range of 20--50%. Are these values significant to cause behavioral changes? Reductions in the order of 30% of excitatory or inhibitory synapses in adult *Drosophila* local olfactory interneurons transform perception of certain odorants from attraction to repulsion and vice versa \[[@pone.0184238.ref010]\]. In schizophrenia patients, a 16% loss of inhibitory synapses in the brain cortex has been reported \[[@pone.0184238.ref012]\]. In *Rhesus* monkeys, the pyramidal neurons in layer III of area 46 in dorsolateral prefrontal cortex show a 33% spine loss, and a significant reduction in learning task performance during normal aging \[[@pone.0184238.ref111]\]. Thus, it seems that behavior is rather sensitive to small changes in synapse number irrespective of the total brain mass.

The signaling interactions analyzed here were chosen because they were reported in other cellular systems and species previously. Some of these interactions have been confirmed (e.g.: Gbb/Wit), while others have proven ineffective in the context of synaptogenesis (e.g.: Ras85D/PI3K binding). Likely, the two signaling pathways, pro- and anti-synaptogenesis, are not the only ones relevant for synapse formation. For example, in spite of the null condition of the *gbb* and *wit* mutant alleles used here, the resulting synaptic phenotypes are far less extreme than expected if these two factors would be the only source of signaling for synaptogenesis. Although it could be argued that the incomplete absence of synapses in the mutant phenotypes could result from maternal perdurance, Wit is not part of the oocyte endowment while Gbb is. Three alternative possibilities may be considered, additional ligands for Wit, additional receptors for Gbb, and a combination of the previous two. Beyond the identity of these putative additional ligands and receptors, the stoichiometry between ligands and receptors may certainly be relevant. Actually, Gbb levels are titrated by Crimpy \[[@pone.0184238.ref068], [@pone.0184238.ref071]\]. An equivalent quantitative regulation could operate on Wit. The reported data on Wit illustrate already the diversity of the functional repertoire of this receptor. Wit can form heteromeric complexes with Thick veins (Tkv) or Saxophone (Sax) receptors to receive Dpp/BMP4 or Gbb/BMP7 as ligands \[[@pone.0184238.ref112], [@pone.0184238.ref113]\]. However, the same study also showed that Wit could dimerize with another receptor, Baboo, upon binding of Myoglianin to activate a different and antagonistic signaling pathway, TGFβ/activin-like \[see also \[[@pone.0184238.ref114], [@pone.0184238.ref115]\]\].

The Gbb/Wit/PI3K signaling analyzed here is likely not the only pro-synaptogenesis pathway in flies and vertebrates. The ligand wingless (Wg), member of the Wnt family, and the receptors Frizzled have been widely documented as relevant in neuromuscular junction development, albeit data on synapse number are scant \[[@pone.0184238.ref116], [@pone.0184238.ref117]\]. Interestingly, however, the downstream intermediaries can be as diverse as those mentioned above for Wit \[[@pone.0184238.ref118]\]. Although generally depicted as linear pathways, a more realistic image would be a network of cross-interacting signaling events whose in situ regulation and cellular compartmentalization remains fully unexplored.

The quantitative regulation of receptors is most relevant to understand their biological effects. In that context, is worth noting that Tkv levels are distinctly regulated from those of Wit and Sax through ubiquitination in the context of neurite growth \[[@pone.0184238.ref119]\]. On the other hand, although the receptor Wit is considered a RSTK type \[[@pone.0184238.ref120]\], the functional link with PI3K is a feature usually associated to the RTK type instead. The link of Wit with a kinase has a precedent with LIMK1 that binds to, and is functionally downstream from, Wit in the context of synapse stabilization \[[@pone.0184238.ref090]\]. Thus, Wit should be considered a wide spectrum receptor in terms of its ligands, co-receptor partners and, consequently, signaling pathways elicited. Actually, the Wit amino acid sequence shows both, Tyr and Ser/Thr motifs justifying its initial classification as a "dual" type of receptor (<http://flybase.org>). In this report we have not determined if Wit heterodimerizes with other receptors, as canonical RSTKs do, or if it forms homodimers, as canonical RTKs do. However, the lack of synaptogenesis effects by the putative co-receptors, Tkv and Sax, and the phenotypic similarity with the manipulation of the standard RTK signaling effector Cic, leaves open the possibility that Wit could play RTK-like functions, at least in the context of synaptogenesis.

Consistent with the proposal of a dual mechanism for Wit, its activation seems to be a requirement to elicit two independent signaling steps, PI3K and Ras85D, that could reflect RTK and RSTK mechanisms, respectively. Both steps are independent because the mutated form of PI3K unable to bind Ras85D, PI3K^ΔRBD^, is as effective as the normal PI3K to elicit synaptogenesis. PI3K and Ras85D signaling, however, seem to converge on Bsk revealing a novel feature of this crossroad point. The activity level of Bsk is known to be critical in many signaling processes \[[@pone.0184238.ref121], [@pone.0184238.ref122]\]. The peculiarities of Bsk/JNK activity include its coordinated regulation by p38a and Slpr in the context of stress heat response without interference on the developmental context \[[@pone.0184238.ref123]\]. Another modulator, Puc, was described as a negative feed-back loop in the context of oxidative stress \[[@pone.0184238.ref124]\]. The Puc mediated loop is operative also for synaptogenesis, while that of p38a/Slpr is relevant for p38a only, as shown here. Further, Ras85D represents an additional regulator in the neural scenario. The triple regulation of Bsk/JNK by Ras85D, Puc and the MAPKs seems to stablish a narrow range of activity thresholds within which normal number of synapses is determined.

The concept of signaling thresholds is also unveiled in this study by the identification of another signaling pathway that opposes synapse formation. The pro- and anti-synaptogenesis pathways have similar constituents, including small GTPases, MAPKs and transcriptional effectors, Mad/Smad, which are canonical for RSTK receptors. The RSTK type II receptor Put, which can mediate diverse signaling pathways according to the co-receptor bound \[[@pone.0184238.ref125]\] can be discarded in either the pro- or the anti-synaptogenesis pathways. Thus, the main receptor for the anti-synaptogenesis pathway remains to be identified.

Concerning small GTPases, the pro-synaptogenesis pathway uses Ras85D while its counterpart uses the poorly studied Ras64B. The anti-synaptogenesis pathway includes an additional member of this family of enzymes, Rala. This small GTPase plays a role in the exocyst-mediated growth of the muscle membrane specialization that surrounds the synaptic bouton as a consequence of synapse activity \[[@pone.0184238.ref107]\]. That is, Rala can influence synapse physiology acting from the postsynaptic side. The experimental expression of a constitutively active form of Rala in the neuron does not seem to affect the overall synaptic terminal branching \[[@pone.0184238.ref107]\]. However, the null *ral* mutant shows reduced synapse branching and its vertebrate homolog is expressed in the central nervous system \[[@pone.0184238.ref126]\]. We found here that Rala under-expression in neurons yields an elevated number of synapses. Thus, it is likely that this small GTPase acts as a break to synaptogenesis, hence its inclusion in the antagonistic pathway.

Synaptogenesis and neuritogenesis are distinct processes since each one can be differentially affected by the same mutant (e.g.: Hiw). Both features, however, share some signals (e.g.: Wnd, Hep). This signaling overlap is akin to the case of axon specification versus spine formation for constituents of the apico/basal polarity complex Par3-6/aPKC \[[@pone.0184238.ref127]\]. These and other examples illustrated in this study underscore the need to discriminate between synapses and boutons. This study is focused on the cell autonomous signaling that takes place in the neuron. Non-cell autonomous signals (e.g.: originated in the glia or hemolymph circulating) have not been considered. The active role of glia in axon pruning and bouton number has been the subject of other studies \[[@pone.0184238.ref128], [@pone.0184238.ref129]\]. Considering the reported role of Hiw through the midline glia in the remodeling of the giant fiber interneuron \[[@pone.0184238.ref091]\] it is not unlikely that the glia-to-neuron signaling may share components with the neuron autonomous signaling addressed here.

The summary scheme ([Fig 6](#pone.0184238.g006){ref-type="fig"}) describes the scenario where two signaling pathways mutually regulate each other. Epistasis assays are the only experimental approach for *in vivo* studies of more than one signaling component, albeit this type of assay is only feasible in *Drosophila*. The corresponding protein acronyms in humans are shown in parenthesis in [Fig 6](#pone.0184238.g006){ref-type="fig"}. Thus, it is plausible that vertebrate synaptogenesis will be regulated by a similar antagonistic signaling.

The regulatory equilibrium as a mechanism to determine a biological parameter is the most relevant feature in this scenario for several reasons. First, because this type of mechanism can respond very fast to changes in the physiological status of the cell, and, second because it provides remarkable precision to the trait to be regulated, synapse number in this case \[see \[[@pone.0184238.ref130]\]\]. Although bi-stable regulatory mechanisms are known in other contexts, the case of synapse number may seem unexpected because the highly dynamic nature of synapse number has been recognized only recently \[[@pone.0184238.ref001]--[@pone.0184238.ref003], [@pone.0184238.ref070]\]. Consequently, a molecular signaling mechanism endowed with proper precision and time resolution must sustain this dynamic process. The balanced equilibrium uncovered here, although most likely still incomplete in terms of its components, offers such a mechanism.

Supporting information {#sec017}
======================

###### Synapse visualization.

**A)** Co-localization of synapse markers. Active zones are labeled in red with nc82 antibody while postsynaptic densities are shown in green (anti-GluRIID). The motor neuron membrane is shown in blue by the anti-HRP antibody. Note the correspondence of nc82 and GluRIID spots. **B)** The overexpression of the transcriptional repressor *capicua* (Cic) reduces synapses to the same level as the *wit*^*A12*^*/wit*^*B11*^ mutant (see also main [Fig 1C](#pone.0184238.g001){ref-type="fig"}). The dependence on *capicua* and the signaling through PI3K suggest that Wit may act as a RTK rather than a Ser/Thr kinase receptor. **C)** Postsynaptic FGFR-like receptors. The heterozygous mutant conditions for muscle receptors Htl or Btl increase synapse number. This is consistent with a repressive role in the levels of Gbb and, thus, in the increased pro-synaptogenesis signaling (see also [S2 Fig](#pone.0184238.s002){ref-type="supplementary-material"}). Genotypes: **Control** = *D42-Gal4/+*. **Cic↑** = *D42-Gal4/UAS-cic*. **Htl↓** = *htl*^*AB42*^*/+; D42-Gal4/+*. **Btl↓** = *btl*^*dev1*^*/+; D42-Gal4/+*. Bar in **A** = 5 μm. Number of independent larvae analyzed is shown in parenthesis. A single NMJ from abdominal segment A3 was analyzed per larvae.

(TIF)

###### 

Click here for additional data file.

###### Transcriptional effects on receptors and ligand-encoding genes in the muscle.

**A**) Based on q-PCR assays, Gbb expression is increased as a result of the haploinsufficiency of Htl receptor. By contrast, the haploinsufficiency of Btl receptor leads to the opposite effect illustrating their antagonistic regulation on Gbb expression. The up- or down-regulation of PI3K in neurons has no effect on Gbb transcription. This result indicates that PI3K does not alter *gbb* transcription in the neuron nor triggers a signaling that could have modified that transcription in the muscle (see main text). **B-D**) The neural manipulation of PI3K has no effect on the Htl ligands, Pyramus (Pyr) (**B**) and Thisbe (Ths) (**C**), or on the Btl ligand Branchless (Bnl) (**D**). Genotypes: **+** = *elav-Gal4/+*. **Htl↓** = *htl*^*AB42*^*/+*. **Btl↑** = *btl*^*dev1*^*/+*. **PI3K↑** = *UAS-PI3K/+; elav-Gal4/+*. **PI3K↓** = *UAS-PI3K*^*DN*^*/+*; *elav-Gal4/+*.

(TIF)

###### 

Click here for additional data file.

###### Synaptogenesis and neuritogenesis are two different processes.

**A-D**) Representative images of NMJs. The number of active zones and the size of the motor neuron deviate in opposite directions in *Hiw↓*. Motor neuron branches are more extensive than control but have fewer synapses. Also, note the frequent location of synapses, nc82 puncta, outside of boutons, particularly in Hiw↓. See also [S3 Table](#pone.0184238.s006){ref-type="supplementary-material"}. Genotypes: **A** = *D42-Gal4/+*. **B** = *UAS-Wnd/+*; *D42-Gal4/+*. **C** = *UAS-Hep/+*; *D42-Gal4/+*. **D** = males *hiw*^*ND8*^*; +/+; D42-Gal4/+*. Bar in **A** = 20 μm.

(TIF)

###### 

Click here for additional data file.

###### Receptors without effect in synaptogenesis.

(DOCX)

###### 

Click here for additional data file.

###### Number of synapses (raw data).

(XLS)

###### 

Click here for additional data file.

###### Number of boutons versus number of synapses.

(DOC)

###### 

Click here for additional data file.

###### 3D reconstruction of a NMJ.

(AVI)

###### 

Click here for additional data file.
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